- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05129124
Insertion Clinical Study to Evaluate the Orientation Characteristics of Multiple Kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
July 8, 2025 updated by: Bausch & Lomb Incorporated
The objective is to evaluate the fit characteristics (primary gaze orientation, rotational recovery, and movement) of kalifilcon A daily disposable toric lenses as compared to commercially available Ultra for Astigmatism lenses.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Rochester, New York, United States, 14609
- Bausch and Lomb Site 01
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Be 18 years or older on the date the Informed Consent Form (ICF) is signed and have capacity to read, understand and provide written voluntary informed consent.
- Have physiologically normal anterior segments not exhibiting clinically significant biomicroscopy findings.
- Have no active ocular disease or allergic conjunctivitis.
- Not be using any topical ocular medications.
- Be willing and able to follow instructions.
- Have signed a statement of informed consent.
Exclusion Criteria:
- Participating in a conflicting study.
- Considered by the Investigator to not be a suitable candidate for participation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: T01: +6.00 -2.75 x 180
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
|
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
|
|
Experimental: T02: +6.00-2.75 x 090
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
|
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
|
|
Experimental: T03: -3.00-2.75 x180
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
|
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
|
|
Experimental: T04: -3.00 -2.75 x 090
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
|
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
|
|
Experimental: T05: -9.00 -2.75 x 180
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
|
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
|
|
Experimental: T06: -9.00 -2.75 x 090
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
|
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
|
|
Experimental: T07: -12.00 -2.75 x 180
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
|
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
|
|
Experimental: T08: -12.00-2.75 x 090
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
|
kalifilcon A Daily Disposable Toric LD213001 Contact Lenses at different fittings
|
|
Active Comparator: C01: +6.00 -2.75 x 180
Commercially available Ultra for Astigmatism Contact Lenses
|
Commercially available Ultra for Astigmatism Contact Lenses at different fittings
|
|
Active Comparator: C02: +6.00-2.75 x 090
Commercially available Ultra for Astigmatism Contact Lenses
|
Commercially available Ultra for Astigmatism Contact Lenses at different fittings
|
|
Active Comparator: C03: -3.00-2.75 x180
Commercially available Ultra for Astigmatism Contact Lenses
|
Commercially available Ultra for Astigmatism Contact Lenses at different fittings
|
|
Active Comparator: C04: -3.00 -2.75 x 090
Commercially available Ultra for Astigmatism Contact Lenses
|
Commercially available Ultra for Astigmatism Contact Lenses at different fittings
|
|
Active Comparator: C05: -9.00 -2.75 x 180
Commercially available Ultra for Astigmatism Contact Lenses
|
Commercially available Ultra for Astigmatism Contact Lenses at different fittings
|
|
Active Comparator: C06: -9.00 -2.75 x 090
Commercially available Ultra for Astigmatism Contact Lenses
|
Commercially available Ultra for Astigmatism Contact Lenses at different fittings
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean Absolute Primary Gaze Orientation at 3 Minutes for the Lenses Inserted at 90 Degrees
Time Frame: 3 minutes
|
Primary gaze orientation is measured in degrees.
Measurement Description: Primary gaze is when the patient is looking straight ahead.
Orientation refers to how much the contact lens is rotated on the eye.
Primary gaze orientation of the contact lens is measured in degrees at the slit-lamp (microscope) using a reticle (protractor).
Lens orientation was measured in primary gaze in 5-degree increments.
Negative values indicate the contact lens was rotated in the temporal direction.
Positive values indicate the contact lens was rotated in the nasal direction.
The greater the value (positive or negative) the more the lens is rotated.
The absolute value was calculated for all the measurements.
The absolute values were used to calculate the mean primary gaze orientation after 3 minutes of contact lens wear.
Criteria: P-values ≤0.05 will be considered statistically significant.
|
3 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jeffery Schafer, OD, Bausch & Lomb Incorporated
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 30, 2021
Primary Completion (Actual)
January 13, 2022
Study Completion (Actual)
January 13, 2022
Study Registration Dates
First Submitted
November 10, 2021
First Submitted That Met QC Criteria
November 10, 2021
First Posted (Actual)
November 22, 2021
Study Record Updates
Last Update Posted (Actual)
July 10, 2025
Last Update Submitted That Met QC Criteria
July 8, 2025
Last Verified
July 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21-012
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ohio State UniversityAlcon ResearchCompletedAstigmatism BilateralUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
CooperVision, Inc.Completed
-
Cairo UniversityUnknown
Clinical Trials on kalifilcon A Daily Disposable Toric LD213001 Contact Lenses
-
Bausch & Lomb IncorporatedCompletedAstigmatism | MyopiaUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearerUnited States
-
Ohio State UniversityCompletedContact LensUnited States
-
Bausch & Lomb IncorporatedCompletedContact Lens WearUnited States
-
Bausch & Lomb IncorporatedCompleted
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
State University of New York College of OptometryJohnson & Johnson Vision Care, Inc.CompletedAsthenopia | Contact Lenses | Ocular Accommodation | Convergence, ExcessUnited States
-
CooperVision, Inc.Completed
-
Bausch & Lomb IncorporatedCompletedMyopiaUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States